Up a level |
Rothan, H.A. and Amini, E. and Faraj, F.L. and Golpich, M. and Teoh, T.C. and Gholami, K. and Yusof, R. (2017) NMDA receptor antagonism with novel indolyl, 2-(1,1-Dimethyl-1,3-dihydro-benzo[e]indol-2-ylidene)-malonaldehyde, reduces seizures duration in a rat model of epilepsy. Scientific Reports, 7 (1). p. 45540. ISSN 2045-2322, DOI https://doi.org/10.1038/srep45540.